BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3020782)

  • 1. Gag-derived but not abl-derived determinants are exposed on the surface of Abelson virus-transformed cells.
    Schiff-Maker L; Rosenberg N
    Virology; 1986 Oct; 154(2):286-301. PubMed ID: 3020782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus.
    Prywes R; Hoag J; Rosenberg N; Baltimore D
    J Virol; 1985 Apr; 54(1):123-32. PubMed ID: 2983109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.
    Yi CR; Rosenberg N
    J Virol; 2007 Sep; 81(17):9461-8. PubMed ID: 17596313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
    Prywes R; Foulkes JG; Rosenberg N; Baltimore D
    Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.
    Rotter V; Witte ON; Coffman R; Baltimore D
    J Virol; 1980 Nov; 36(2):547-55. PubMed ID: 6159484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules.
    Schiff-Maker L; Burns MC; Konopka JB; Clark S; Witte ON; Rosenberg N
    J Virol; 1986 Mar; 57(3):1182-6. PubMed ID: 3005619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts.
    Daley GQ; McLaughlin J; Witte ON; Baltimore D
    Science; 1987 Jul; 237(4814):532-5. PubMed ID: 2440107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the v-abl gene product at cell-substratum contact sites in Abelson murine leukemia virus-transformed fibroblasts.
    Rohrschneider LR; Najita LM
    J Virol; 1984 Aug; 51(2):547-52. PubMed ID: 6086963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells.
    Witte ON; Rosenberg N; Paskind M; Shields A; Baltimore D
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2488-92. PubMed ID: 209468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.
    Rosenberg N; Witte ON
    J Virol; 1980 Jan; 33(1):340-8. PubMed ID: 6245237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
    Warren D; Griffin DS; Mainville C; Rosenberg N
    J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membrane.
    Pillemer EA; Kooistra DA; Witte ON; Weissman IL
    J Virol; 1986 Feb; 57(2):413-21. PubMed ID: 2418213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of syngeneic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface.
    Witte ON; Rosenberg N; Baltimore D
    J Virol; 1979 Sep; 31(3):776-84. PubMed ID: 92572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism.
    Pierce JH; Di Fiore PP; Aaronson SA; Potter M; Pumphrey J; Scott A; Ihle JN
    Cell; 1985 Jul; 41(3):685-93. PubMed ID: 2988783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression of Abelson murine leukemia virus.
    Witte ON; Rosenberg N; Baltimore D
    Prog Clin Biol Res; 1980; 41():757-64. PubMed ID: 6256775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the Abelson murine leukemia virus transforming protein.
    Witte ON; Ponticelli A; Gifford A; Baltimore D; Rosenberg N; Elder J
    J Virol; 1981 Sep; 39(3):870-8. PubMed ID: 6270355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homolog.
    Ponticelli AS; Whitlock CA; Rosenberg N; Witte ON
    Cell; 1982 Jul; 29(3):953-60. PubMed ID: 6185233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.